Third Rock rais­es a record $770M to back its own brand of biotech star­tups — while 1 key part­ner ex­its

The ven­ture cap­i­tal wag­on in biotech keeps rolling along at a grow­ing speed.

Third Rock Ven­tures re­ports this morn­ing that it has raised a record $770 mil­lion fund for its next wave of in­vest­ments in the life sci­ences field. Go­ing deep, the VC group told Bloomberg that they’ll prob­a­bly re­serve those funds for on­ly 10 to 12 biotech star­tups as the part­ners look for their next Agios or blue­bird.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.